Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
3.51 Up 0.08(2.33%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:3.43
Open:3.45
Bid:N/A
Ask:3.89 x 4500
1y Target Est:13.50
Beta:2.951
Next Earnings Date:N/A
Day's Range:3.46 - 3.76
52wk Range:2.55 - 7.50
Volume:44,174
Avg Vol (3m):179,076
Market Cap:46.94M
P/E (ttm):N/A
EPS (ttm):-2.88
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIUp 2.33%46.94M
AGNUp 1.87%39.97B
ALNYDown 1.37%3.44B
MRNADown 2.86%11.52M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):114.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.21
Quarterly EPS Est (Mar-14) :-0.31
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback